Orbimed Follows Baker Bros and Buys Some Mirati Therapeutics Shares

Orbimed Advisors, a fund focused on the healthcare sector, led by Samuel Isaly, disclosed minutes ago purchasing 125,000 shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX). The fund purchased the shares in one transaction, at a price of $17.50 apiece, increasing its position to a total of 1.3 million shares.

Mirati Therapeutics, Inc

Through the acquisition, Orbimed follows Baker Bros., which recently disclosed buying 400,000 shares of Mirati.

Disclosure: none

Recommended Reading:

Mario Gabelli Takes +5% Stakes in Global Sources Ltd and Belo Corp

Howard Marks Discloses 6.8% of Contango Oil & Gas, Affiliates Close Out of Crimson Exploration

4 Hedge Funds Heavily Invested in Apple’s Fate